Why do inhibitors arise in patients with haemophilia A?
- 1 June 1999
- journal article
- review article
- Published by Wiley in British Journal of Haematology
- Vol. 105 (3), 584-590
- https://doi.org/10.1046/j.1365-2141.1999.01396.x
Abstract
No abstract availableThis publication has 33 references indexed in Scilit:
- Recommendations for the treatment of factor VIII inhibitorsBlood Coagulation & Fibrinolysis, 1996
- WHY DO SO MANY HAEMOPHILIA A PATIENTS DEVELOP AN INHIBITOR?British Journal of Haematology, 1995
- The incidence of factor VIII inhibitors in the United Kingdom, 1990‐93British Journal of Haematology, 1995
- Frequency of inhibitor development in haemophiliacs treated with low-purity factor VIIIThe Lancet, 1993
- Mutations in haemophilia ABritish Journal of Haematology, 1993
- Incidence of development of factor VIII and factor IX inhibitors in haemophiliacsThe Lancet, 1992
- Haemophiliacs with factor VIII inhibitors in Finland: prevalence, incidence and outcomeBritish Journal of Haematology, 1990
- Histocompatibility antigen patterns in haemophilic patients with factor VIII antibodiesBritish Journal of Haematology, 1990
- High frequency of HLA‐DR5 in Greek patients with haemophilia A and haemophilia BTissue Antigens, 1986
- Treatment of haemophilia and related disorders in Britain and Northern Ireland during 1976-80: report on behalf of the directors of haemophilia centres in the United Kingdom.BMJ, 1983